In silicon desinging of RANKL-targeting vaccine for protection of osteoporosis based on the epitope of Denosumab
DR3 vaccine was aroused to benefit the prevention and treatment of osteoporosis, and other bone-resorptive diseases potentially.
Authors
- Jianzhou Luo (ORCID: https://orcid.org/0009-0000-1302-4448)
- Lei Tan (ORCID: https://orcid.org/0000-0002-8473-4911)
- Bin Guan (ORCID: https://orcid.org/0000-0002-5210-6216)
- Lin Li (ORCID: https://orcid.org/0000-0002-2516-5827)
- Huiren Tao
- Tailin Wu
- Zili Yang
- Bobo Zhang (ORCID: https://orcid.org/0000-0003-3663-4331)
Institutions
- Xi'an Honghui Hospital (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- Shenzhen University Health Science Center (CN)
- Shenzhen Institutes of Advanced Technology (CN)
- Community Health Center (US)
- University of Hong Kong (HK)
Publication Details
- Journal
- International Immunopharmacology
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1016/j.intimp.2024.113610
- Citations
- 2
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.47